Obesity Research at Johns Hopkins

Technology Licensing

The following is a sampling of unlicensed technologies related to obesity from Johns Hopkins University. A full list of our technologies is available at our searchable database at jhu.technologypublisher.com.

Compounds and Methods to Decrease Obesity-related Hepatic Fat Accumulation and Serum Glucose

Germline and Conditional Deletion of Tardbp

Peptides for treating and preventing metabolic diseases

Predicting infection severity and antibody treatment

Presence of a Novel Protective Anti-inflammatory Receptor in Human Mitochondria and Its Role in Preserving Mitochondrial Functions

Protein Therapeutic for Diabetes and Obesity

Recombinant CTRP3 as Protein Therapeutics for Non-alcoholic Fatty Liver Disease (NAFLD)

Supramolecular Hydrogel Applications to the Carotid Bodies to Treat Hypertension and Sleep Apnea in Obesity

Treatment of Post-menopausal Obesity and Associated Disease by PDE9 Inhibitors

Use of C1q/TNF-related Protein-1 (CTRP1) to Treat Fatty Liver Disease (steatosis)

Questions?

Have a question about one of our technologies? Connect with Jeanine today.

Jeanine Pennington

Director of Licensing

Telephone 667-306-8218

Email [email protected]

Technology Licensing

Questions?

Jeanine Pennington

Social Navigation

Site Menu